BioNovus Innovations LLC and the University of Kansas Medical Center’s Institute for Advancing Medical Innovation (IAMI) announced a new partnership Tuesday to develop and commercialize new drugs, diagnostics and medical devices. UPCOMING EVENTS Champions of Business Awards Luncheon MAY 10, 2016 CFO of the Year Awards Luncheon 2016 JUNE 09, 2016 See More Events The agreement between the two organizations grants BioNovus — a new venture capital fund in the area comprised of Kansas City investors — with rights to license, develop and commercialize medical innovations advanced through IAMI.
